Arthritis | Xconomy

by in

Entry	Blogger	Date ▴	Location
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month	Luke Timmerman	11/20/08	Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says	Luke Timmerman	11/13/08	Boston
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure	Luke Timmerman	11/04/08	Boston
Trubion Shares Leap, Drop, Leap Again After Encouraging Clinical Trial News	Luke Timmerman	10/27/08	Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk	Luke Timmerman	10/27/08	Seattle
ZymoGenetics Gets $21M From Bristol-Myers To Settle Patent Suit	Luke Timmerman	10/23/08	Seattle
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial	Luke Timmerman	10/06/08	Boston
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way	Luke Timmerman	09/30/08	Boston
Ariad Loses Patent Case Against Amgen	Luke Timmerman	09/22/08	Boston
Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy	Luke Timmerman	09/18/08	Seattle
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors	Luke Timmerman	08/26/08	Seattle
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge	Luke Timmerman	08/14/08	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.